COVID 19 antibody test | sciencenewsnet.in

Breaking News

A new study highlights microalgae as sustainable ingredients for food and pharmaceutical applications

Nitric oxide treatment preserves fresh walnuts, reduces decay, and maintains quality

Researchers Develop High-Tech Methods to Stem the Flow of Fentanyl

Research Shows Cleveland Clinic’s Therapeutic Virtual Yoga Program Can Be Effective for Chronic Low Back Pain

CSUDH Political Experts Available for Election Coverage

Political Science Faculty Weigh in on 2024 Election

Long Beach Lakewood Orthopedic Institute Joins Commons Clinic, Strengthening Comprehensive Orthopedic Care Services in Long Beach

National Comprehensive Cancer Network Joins with Vietnam National Cancer Hospital to Enhance Cancer Treatment

Fueling greener aviation with hydrogen

Don’t Let Diabetes Dim Your Vision

02 Nov, 2024

New study finds reinfection by SARS-CoV-2 in healthy young adults is common

February 1, 2021 sarah JonasResearch Alert

MEDIA ADVISORY Paper title: SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study Corresponding Author: Stuart C. Sealfon, MD, Professor of Neurology, Neuroscience and Pharmacological Sciences, Icahn School of Medicine at Mount Sinai Bottom Line: Although…

Baylor Scott & White Health Enrolls First Patients in the World in Trial for Inhaled Remdesivir

October 2, 2020 sarah JonasFeature

Earlier this month, Baylor Scott & White Research Institute enrolled the first four patients in the world on Gilead’s new clinical trial involving an investigational inhaled solution of remdesivir (NCT04539262). This is Gilead’s first trial in COVID-19 patients examining the safety and efficacy of an inhaled solution of the drug in an outpatient setting. The study of an inhaled solution asks whether this mode of delivery can help reduce the amount of virus from the airways earlier.